Noncompaction cardiomyopathy laboratory studies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
*[[3-methylgluconic aciduria]] | *[[3-methylgluconic aciduria]] | ||
==References== | |||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 11:55, 6 August 2011
|
Noncompaction Cardiomyopathy Microchapters |
|
Pathophysiology |
|---|
|
Differentiating Noncompaction Cardiomyopathy from other Diseases |
|
Diagnosis |
|
Treatment |
|
Noncompaction cardiomyopathy laboratory studies On the Web |
|
Risk calculators and risk factors for Noncompaction cardiomyopathy laboratory studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Consideration should be given to testing for the presence of Barth Syndrome which includes the following [1]:
References
- ↑ Botto, LD. Left ventricular noncompaction. Orphanet encyclopedia. http://www.orpha.net/data/patho/GB/uk-LVNC.pdf